GenoGenix LLC
Has GenoGenix LLC received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued GenoGenix LLC a warning letter naming semaglutide, tirzepatide and retatrutide, dated Jan 20, 2026, with the FDA subject line “Compounding Pharmacy/Adulterated Drug Products.” openFDA also lists 4 drug recall reports for the firm naming semaglutide, tirzepatide and retatrutide.
FDA records in this index name GenoGenix LLC from Jul 30, 2025 to Jan 20, 2026. It is listed on FDA’s registered 503B outsourcing facility list: GenoGenix LLC, Raton, FL.
- Names in FDA records
- GenoGenix LLC; GenoGenix LLC
- Type named in FDA records
- Compounding pharmacy, 503B outsourcing facility
- FDA warning letters
- 1
- Drug recall reports
- 4
- Drugs named
- Semaglutide, Tirzepatide, Retatrutide
- Latest record
- Jan 20, 2026
- 503B location
- Raton, FL
- 503B last inspection
- Jul 18, 2025
- Form 483 issued
- Yes
- Action on last inspection
- Open
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Jan 20, 2026 | Compounding Pharmacy/Adulterated Drug Products | Semaglutide, Tirzepatide, Retatrutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Jan 20, 2026: … on file for the drug products that you repackage, such as Semaglutide , Tirzepatide, and Retatrutide. 6 Under sections … their intended uses. You repackage drug products, such as Semaglutide , Tirzepatide, and Retatrutide, that are intended … Full letter
Drug recalls
| Record | |||||
|---|---|---|---|---|---|
| Jul 30, 2025 | Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as m... | Lack of Assurance of Sterility | Class II | Ongoing | D-0091-2026 |
| Jul 30, 2025 | Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. | Lack of Assurance of Sterility | Class II | Ongoing | D-0083-2026 |
| Jul 30, 2025 | Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labe... | Lack of Assurance of Sterility | Class II | Ongoing | D-0092-2026 |
| Jul 30, 2025 | Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 | Lack of Assurance of Sterility | Class II | Ongoing | D-0093-2026 |
FDA compounding inspections and actions
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists one facility under this exact legal name. These entries cover all of the facility’s compounding, not only GLP-1 drugs.
GenoGenix, LLC, Boca Raton, FL (503B)
2 listed actions, including 1 Form 483 and 1 warning letter (2025 to 2026).
| Document | |||
|---|---|---|---|
| Jan 20, 2026 | Warning letter | Warning Letter (01/20/2026) | fda.gov |
| Jul 18, 2025 | Amended Form 483 | Amended 483 Issued 07/18/2025 | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.
Pharmacy pages with the same legal name, built from FDA’s 503B list and compounding inspections and actions page: GenoGenix, LLC, Boca Raton, FL, GenoGenix LLC, Raton, FL.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
- FDA warning letter, Jan 20, 2026
- openFDA drug recall enforcement reports
- FDA Registered Outsourcing Facilities (503B)
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA warning letters (fda.gov full-text search)
Records last pulled Nov 15, 2026. Every entry links to the original public record.